监管审批
共 12 条1
Pharmaceutical Executive Daily: Amazon Pharmacy to Offer GLP-1 Delivery Service
Amazon Pharmacy推出GLP-1药物配送服务，扩大减重药可及性。
阅读原文 →2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
FDA加速批准Tudriqev联合Nivolumab用于晚期黑色素瘤。
阅读原文 →5
Replimune wins FDA approval after melanoma drug was twice rejected
Replimune黑色素瘤药物两次被拒后终获FDA批准。
阅读原文 →临床试验
共 12 条1
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial
FDA将召开咨询委员会，讨论Grail在大型随机试验中失败的癌症检测。
阅读原文 →2
BioMarin discontinues rare disease drug; CSL and Arcturus split up
BioMarin停用罕见病药物；CSL与Arcturus终止合作。
阅读原文 →4
FDA details pilot plan to expedite new drugs, eyeing up to 10 programs
FDA详述试点计划，拟加速新药审批，目标最多10个项目。
阅读原文 →交易速览
共 11 条1
FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine
FDA紧急授权新药预防多种动物（羊、牛、山羊、猪）的新世界螺旋蝇感染。
阅读原文 →2
Ecopetrol Announces the Convening of Bondholders' Meetings for Domestic Public Debt Bonds on August 18
Ecopetrol宣布8月18日召开国内公债持有人会议。
阅读原文 →3
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue
STAT+：NIH拟限制国际签证研究人员获取关键资助渠道。
阅读原文 →4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
Tarsus Pharmaceuticals以4.5亿美元收购Alkeus Pharmaceuticals。
阅读原文 →行业动态
共 42 条1
Greenberg Traurig's Friederike Görgens Named Law360 Rising Star
Greenberg Traurig的Friederike Görgens获评Law360新星。
阅读原文 →2
Wildfires Reveal the Risks of a Net Zero Electricity Grid as Climate Activists and Politicians Exploit Wildfire Tragedies says Friends of Science Society
野火揭示净零电网风险，气候活动家与政客利用悲剧。
阅读原文 →3
NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Kessler Topaz律所提醒Medline Inc.投资者联系。
阅读原文 →4
Zum Sees Strong Driver Hiring Momentum as More Than 200 Drivers and Families Celebrate New Philadelphia Operations Center
Zum在费城新运营中心庆祝，司机招聘势头强劲。
阅读原文 →5
Costa Rica promotes the development of specialized talent for high-demand, high-value industries through PROCOMER
哥斯达黎加通过PROCOMER培养高需求高价值产业人才。
阅读原文 →亦庄园区动态
共 1 条论文研究
共 10 条1
Preclinical targeted alpha therapy of B7-H3-positive tumors using [ 225 Ac]Ac-Macropa-PEG 2 -enoblituzumab via EDC/NHS-mediated conjugation.
期刊：225Ac标记enoblituzumab靶向B7-H3肿瘤的临床前研究。
阅读原文 →2
Quantifying Porosity-Linked Mechanical Behaviour of Renal Tubular Epithelial Cells by Poroviscoelastic Modelling and AFM Nanoindentation.
通过多孔粘弹性模型与AFM纳米压痕量化肾小管上皮细胞孔隙相关力学行为。
阅读原文 →3
Photobiomodulation and pelvic floor training for genitourinary syndrome: RCT results.
光生物调节联合盆底训练治疗泌尿生殖综合征：随机对照试验结果公布。
阅读原文 →5
Premarket Clinical Evidence Strength and Recalls of High-Risk Therapeutic Medical Devices.
高风险治疗性医疗器械的上市前临床证据强度与召回关联分析。
阅读原文 →政策追踪
共 3 条政策与观点
共 4 条1
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
综述：AI在药物发现中的现状与未来路径。
阅读原文 →3
Opinion: AI won’t enhance physician autonomy. It will further diminish it
观点：AI不会增强医生自主性，反而会进一步削弱。
阅读原文 →4
Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack
观点：CDC遭枪击一年后，机构仍面临攻击。
阅读原文 →